Actively Recruiting
Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions
Led by Viome · Updated on 2025-01-29
150
Participants Needed
1
Research Sites
163 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
US residents who have obesity and sign the informed consent form and are screened and enrolled for this study. Participants who are enrolled complete a survey upon enrollment and are randomized into one of three arms. This study is direct to participant and will not utilize clinical sites.
CONDITIONS
Official Title
Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Resident of the United States
- Female or male aged 25 to 75 years
- Able to speak and read English
- No unexplained weight loss, fevers, anemia, or blood in stool
- Willing and able to follow the trial instructions
- Signed and dated informed consent before any trial procedures
- Fasting insulin level of 15 uIU/mL or higher or fasting glucose of 100 mg/dL or higher within the last 3 months, verified from medical records
You will not qualify if you...
- Unwilling to change current diet
- Unwilling to go to Quest
- Prior use of Viome products or services
- Antibiotic use in the previous 4 weeks
- Pregnant, breastfeeding, or less than 90 days postpartum
- Active infection
- Unable or unwilling to use Viome's app on an iPhone or Android smartphone
- Significant diet or lifestyle changes in the previous month
- Diagnosis of inflammatory bowel disease
- Use of investigational drugs, products, or devices within 1 month before and 4 months after trial start
- Cancer therapy within the previous year
- Major surgery in the last 6 months or planned in the next 4 months
- Current or previous use of insulin-increasing medications or exogenous insulin
- Prescribed drugs that may interact with the supplements
- Medical conditions or allergies that interfere with supplement use, including pregnancy, breastfeeding, certain gastrointestinal diseases, kidney or liver conditions, HIV, and multiple specific allergies
- Currently following specific diets such as FODMAP, keto, or paleo
- Gastrointestinal diseases including esophagitis, celiac disease, malignancies, peptic or gastric ulcers, except appendectomy and benign polypectomy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Viome Life Sciences
Bothell, Washington, United States, 98011
Actively Recruiting
Research Team
M
Mory Mehrtash
CONTACT
M
Momchilo Vuyisich
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here